These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32160868)

  • 21. Effect of 6-OHDA on hypercapnic ventilatory response in the rat model of Parkinson's disease.
    Andrzejewski K; Budzińska K; Kaczyńska K
    Physiol Res; 2019 Apr; 68(2):285-293. PubMed ID: 30628829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety.
    Vieira JCF; Bassani TB; Santiago RM; de O Guaita G; Zanoveli JM; da Cunha C; Vital MABF
    Behav Brain Res; 2019 Oct; 371():111981. PubMed ID: 31141725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression of dopamine receptors in cholinergic motoneurons of the hypoglossal nucleus in a 6-OHDA-induced Parkinson's disease rat model.
    Zhou L; Wang ZY; Lian H; Song HY; Zhang YM; Zhang XL; Fan RF; Zheng LF; Zhu JX
    Biochem Biophys Res Commun; 2014 Sep; 452(3):560-6. PubMed ID: 25172664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model.
    Van Keuren KR; Stodgell CJ; Schroeder SR; Tessel RE
    Brain Res; 1998 Jan; 780(1):56-66. PubMed ID: 9473587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation and blockade of serotonin
    Guo Y; Zhang L; Zhang J; Du CX; Lv SX; Wang T; Wang HS; Xie W; Liu J
    Neurol Res; 2019 Jul; 41(7):585-593. PubMed ID: 30929589
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of the locus coeruleus catecholaminergic neurons in the chemosensory control of breathing in a Parkinson's disease model.
    Oliveira LM; Tuppy M; Moreira TS; Takakura AC
    Exp Neurol; 2017 Jul; 293():172-180. PubMed ID: 28431876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.
    Tadaiesky MT; Dombrowski PA; Figueiredo CP; Cargnin-Ferreira E; Da Cunha C; Takahashi RN
    Neuroscience; 2008 Oct; 156(4):830-40. PubMed ID: 18817851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroencephalographic and respiratory activities during acute intermittent hypoxia in anesthetized rats.
    Budzinska K; Ilasz R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):85-93. PubMed ID: 18204119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent but not sustained moderate hypoxia elicits long-term facilitation of hypoglossal motor output.
    Wilkerson JER; Devinney M; Mitchell GS
    Respir Physiol Neurobiol; 2018 Oct; 256():15-20. PubMed ID: 29074449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
    Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
    Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
    Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
    J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential alteration by hypercapnia and hypoxia of the apneustic respiratory pattern in decerebrate cats.
    St John WM
    J Physiol; 1979 Feb; 287():467-91. PubMed ID: 430430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats.
    Zhang X; Li Y; Liu C; Fan R; Wang P; Zheng L; Hong F; Feng X; Zhang Y; Li L; Zhu J
    Transl Res; 2015 Aug; 166(2):152-62. PubMed ID: 25766133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Life-long impairment of hypoxic phrenic responses in rats following 1 month of developmental hyperoxia.
    Fuller DD; Bavis RW; Vidruk EH; Wang ZY; Olson EB; Bisgard GE; Mitchell GS
    J Physiol; 2002 Feb; 538(Pt 3):947-55. PubMed ID: 11826178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
    Machado-Filho JA; Correia AO; Montenegro AB; Nobre ME; Cerqueira GS; Neves KR; Naffah-Mazzacoratti Mda G; Cavalheiro EA; de Castro Brito GA; de Barros Viana GS
    Behav Brain Res; 2014 May; 264():116-25. PubMed ID: 24525422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.
    Chen MT; Morales M; Woodward DJ; Hoffer BJ; Janak PH
    Exp Neurol; 2001 Sep; 171(1):72-83. PubMed ID: 11520122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease.
    Efange SM; Langason RB; Khare AB; Low WC
    Life Sci; 1996; 58(16):1367-74. PubMed ID: 8614294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.